Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Agenus Inc. is a clinical-stage biotechnology company focused on immuno-oncology, developing therapies that activate the immune system against cancer. Its diverse pipeline includes immune-modulatory antibodies and adoptive cell therapies, with key products like botensilimab and balstilimab in advanced trials. Targeting a significant market opportunity, Agenus aims to enhance treatment outcomes through innovative combination therapies and strategic partnerships, while also advancing vaccine adjuvants via its subsidiary, SaponiQx.
This description was generated via AI from an annual report. Updated about 1 year ago.